Last updated 2026-06-18
- Raised funding round led by aMoon Fund, Jan 2018
Total raised
—
Last: 2018-01
Stage
Seed
Founded
2017
Headcount
10
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Aummune is a clinical stage company developing a first-of-its-kind approach for individualized treatment of solid tumors. Its proprietary platform utilizes a unique efficacy-driven selection process to match and produce a patient-specific tri-functional oligonucleotide drug that safely and synergistically induces cancer cell death and activates both innate and adaptive immune responses.
Aummune’s lead program, AM003, has already initiated its Phase 1 clinical trial following successful demonstrations of efficacy and safety in multiple animal models. The company is now actively recruiting patients for this First-in-Human study, which targets those with locally advanced and metastatic solid tumors.
Funding history · 1 round · — total
2018-01
Undisclosed
Q&A
- What is Aummune's primary focus?
- Aummune is a clinical-stage company developing an individualized treatment approach for solid tumors, utilizing a proprietary platform to produce patient-specific tri-functional oligonucleotide drugs.
- What is the status of Aummune's lead program?
- Aummune's lead program, AM003, has initiated its Phase 1 clinical trial and is actively recruiting patients with locally advanced and metastatic solid tumors.
- When was Aummune founded?
- Aummune was founded in July 2017.
- Who are the co-founders of Aummune?
- Aummune was co-founded by Guy Neev, who also serves as CEO, and Marius Nacht.
- Which sector does Aummune primarily operate in?
- Aummune's primary sector is Health Tech & Life Sciences, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- Has Aummune secured any funding?
- Aummune received funding in January 2018 from aMoon Fund.
- What is Aummune's current product stage?
- Aummune's product is currently in the clinical trial stage.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
immunotherapycancerprecision-medicinehealthcare-providersclinicspersonalized-medicinetreatmentspharmaceuticalscancer-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | aummune.com |
|---|---|
| linkedin.com/company/79060359 |
Identifiers & details
| Founded | 2017-7 |
|---|---|
| Employees (exact) | 10 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Publications (Crossref)
| Works | 5 |
|---|
Web history (Wayback)
| Domain | aummune.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|